Aurélia Vessière, PhD (University Paris Descartes - France), MSc (University of the Mediterranean,Marseille - France), MSc (School for Higher Studies in Social Sciences, Paris - France), PgDip (London
School of Hygiene and Tropical Medicine - UK).
Trained in tropical infectious diseases and virology, Aurélia has extensive experience in clinicalresearch and epidemiology of emerging infectious diseases, as well as HIV, malaria and TB. She mainly
focused on improving diagnosis and patient management in resource-constrained settings, with a «research-to-policy » vision.
She held positions at various public and private institutions including FIND (Switzerland); University ofBordeaux (France); University of Oxford (UK); University of Tulane (USA); French National Agency for
AIDS Research; and Pasteur Institute in Cameroon. She also worked as an independent consultant invirology, and as an expert to the European Commission.
With more than 15 years of experience working in and with sub-Saharan African countries, Aurélia has
been very involved in capacity strengthening of resource-limited health settings, while being strongly
attached to building equitable research partnerships.

Selected recent publications and communicationsHoppe A, Vessiere A, and Bausch DG. Leveraging Covid-19 Diagnostics to Confront both Epidemic and Endemic
Diseases. In: Evaluating Covid-19. Editor Charles Pasternak. World Scientific Publishing, October 2023.
https://doi.org/10.1142/13039
Escadafal C, Baldan R, De Vos M, Ruiz RJ, Emperador DM, Murahwa A, Mace A, Bausch DG, Vessière A, Sacks
JA. Evaluating Diagnostic Tests During Outbreaks: Challenges and Lessons Learned from COVID-19. BMJ GlobHealth. 2023 Jul;8(7):e012506.
Marcy O, Wobudeya E, Font H, Vessière A, et al.; TB-Speed Pneumonia Study Group. Effect of systematictuberculosis detection on mortality in young children with severe pneumonia in countries with high incidence oftuberculosis: a stepped-wedge cluster-randomised trial. Lancet Infect Dis. 2023 Mar;23(3):341-51.
Vessière A, Font H, Gabillard D, et al. Impact of systematic early tuberculosis detection using Xpert MTB/RIF Ultrain children with severe pneumonia in high tuberculosis burden countries: Study protocol for a stepped wedge
cluster-randomized trial (TB-Speed Pneumonia). BMC Pediatr 2021 Mar 20;21(1):136.
Emperador DE, Aroworade V, Mantsoki A, Escadafal C, Mazzola L, Albertini A, Nkeramahame J, Olliaro P,Nakoune P, Kavunga-Membo H, Eckerle I, Dunning J, Ramjeet K, Bausch DG, Vessière A. Filling the information
gap: FIND’S mpox Test Directory and performance evaluations. 72th ASTMH Annual Meeting, 18-22 October 2023.
Vessière A. Changing the diagnostics landscape: what pandemic preparedness means for endemic diseases.
Annual joint meeting of the Swiss Society of Tropical Medicine and Parasitology & Swiss Society of Tropical andTravel Medicine. 10-11 November 2022, Bern, Switzerland.
Emperador D, Fonkeng F, Chi Fru H, Vessiere A, Bausch DG, Kelly-Cirino C. Supporting Lassa Fever Diagnostic
Response in Nigeria, 2018-2021. Global Health Security Conference 2022, 28 June-1 July 2022, Singapore
Bhatta B, Vessière A, et al. Acceptability of nasopharyngeal and stool sample collection in children with severe
pneumonia - parents and health care workers perspective. 52nd Union World Conference on Lung Health, 19-22
October 2021.